Amrize (NYSE:AMRZ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 14.29 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $2.178 billion which beat the analyst consensus estimate of $2.144 billion by 1.57 percent. This is a 4.66 percent increase over sales of $2.081 billion the same period last year.